<DOC>
	<DOCNO>NCT02974374</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics single dose PF-06835919 healthy adult subject .</brief_summary>
	<brief_title>Single Dose PF-06835919 Escalation Study Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Healthy male female nonchildbearing potential ; Body Mass Index 21.5 30.5 kg/m2 ( inclusive ) ; Total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurological , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>